Pharr Recognizes April 17th as Testicular Cancer Awareness Day

Translate to Spanish or other 102 languages!

The proclamation was presented to Mario Lizcano, Administrator of Corporate Affairs for DHR Health, and Claudia Chapa, Community Outreach Coordinator for DHR Health. Image courtesy of The City of Pharr
The proclamation was presented to Mario Lizcano, Administrator of Corporate Affairs for DHR Health, and Claudia Chapa, Community Outreach Coordinator for DHR Health. Image courtesy of The City of Pharr
- Advertisement -

The City of Pharr has declared April 17, 2025, as Testicular Cancer Awareness Day. Testicular cancer, the most common cancer among men aged 15-35, affects over 9,720 men annually, with approximately 600 cases resulting in death. This proclamation recognizes the courage of survivors, supports those currently fighting, and honors those who have lost their lives. It also underscores the crucial role of healthcare workers in improving detection and treatment options.

The proclamation was presented to Mario Lizcano, Administrator of Corporate Affairs for DHR Health, and Claudia Chapa, Community Outreach Coordinator for DHR Health. “We thank you for providing a platform for DHR Health to continue to provide education and community awareness and the opportunity to provide the screenings and testing that are available for all our community,” said Lizcano. 

On Testicular Cancer Awareness Day, the City of Pharr encourages men to consult with their doctors and calls on the community to increase awareness in the ongoing fight against this disease.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

STC Offers EKG Technician Training to Prepare Students for Careers in Healthcare

South Texas College (STC) is offering an electrocardiography (EKG) technician course through its Continuing Education and Workforce Development division, providing students with hands-on training and an opportunity to take the first step toward a career in healthcare. 

FDA Approves First Treatment for Certain People With BCG-Unresponsive Bladder Cancer  

The U.S. Food and Drug Administration expanded the approved use of Anktiva (nogapendekin alfa inbakicept-pmln), given with Bacillus Calmette-Guérin (BCG), to include adults with high-grade papillary-only bladder cancer that has not spread into the bladder muscle and has not responded to BCG treatment.

Do You Want to Be an Angel? This Is Your Opportunity

Becoming an angel for someone facing cancer may be as simple as donating $3 or $5. Through DHR Health’s annual Bras for a Cause fundraiser, community members can help patients experiencing financial difficulties while supporting breast cancer awareness and early detection.

Payne Weslaco Chevrolet Salutes STHS’ ER Heroes with $1,000 Donation

When every second counts, emergency room personnel play a critical role in saving lives. From heart attacks and strokes to serious injuries caused by car crashes, falls and other emergencies, these frontline healthcare professionals are trained to act quickly when patients need them most.
- Advertisement -